Council
of University Heads of Pharmacy : response to withdrawal of funding
for equivalent or lower qualifications (ELQs)
|
Consultation
question 1: Have we responded appropriately to the Government's
instruction that certain categories of student should be exempt in
the light of the Student Fees (Qualifying Courses and Persons) (England)
Regulations and Education (Student Support) Regulations?
|
|
The Council of University Heads of Pharmacy proposes that pharmacy
must be included in the list of exempt subjects. It appears anomalous
that it was omitted from the original Student Fees (Qualifying Courses
and Persons) (England) Regulations and Education (Student Support)
Regulations).
- Pharmacy
is a vocational healthcare profession and should be treated no
differently from all other medical, dental and allied health professions.
- Pharmacists
are on the UK Skills Shortage Occupations List.
- The
shortage of pharmacists is recognised elsewhere - in a 2006 survey
6.5% of junior pharmacist posts in the NHS were vacant (www.nhspedc.nhs.uk/pdf/Report%202006.pdf).
- The
4-year undergraduate Master of Pharmacy degree qualification,
followed by 1-year's pre-registration training, is the only route
to registering with the regulator for pharmacy, the Royal Pharmaceutical
Society of Great Britain.
- Greater
than 95% of students reading for the MPharm qualification proceed
to register and practise as pharmacists (Willis et al.
Pharm J. 2006:277,137-138.)
- Workforce
modelling commissioned by the Royal Pharmaceutical Society, in
partnership with the Department of Health and the Welsh Assembly
Government indicates that over the next 10 years pharmacist numbers
will need to grow by 5% per annum. Even with greater efforts to
increase retention and participation rates in employment a significant
increase in the volume of the training pipeline is indicated.
- This
increased demand for new pharmacy undergraduates combined with
the 18 - 30 year old demographic profile between 2006/7 and 2026/27
means that demand for pharmacy undergraduates will exceed supply
in the traditional recruitment pools. The inability of graduates
to re-train as pharmacists will place a serious constraint on
healthworker development across the NHS and run counter to the
government's goal of getting patient care closer to patients.
- If
workforce demand is to be met substantially by new graduates (in
addition to retention and increasing participation rates) then
pharmacy will need to look to non-traditional recruitment pools
to meet employer-led demand - any barriers to for example graduates
re-training as pharmacists will place a serious constraint on
development of the pharmacy workforce and more generally across
the NHS and run counter to the government's goal of getting patient
care closer to patients.
- Students
highlighted as ELQ in the schools of pharmacy have 'first' qualifications
in the pharmaceutical area, but as stated above the MPharm is
the only vocational qualification leading to registration as a
pharmacist. First degrees in chemistry, medicinal or pharmaceutical
chemistry, pharmacology or related biomedical science predominate.
- The
current proposal makes extremely unlikely that a graduate entry
route into pharmacy, which has been so successful in medicine,
will be a meaningful option.
|
| Consultation
question 2: Do you agree with our proposal to continue providing
public funding for students studying for a foundation degree as an
equivalent or lower qualification (ELQ)? |
This proposal makes no sense at all in the context of the failure
to exempt important qualifications such as pharmacy that have a strong
vocational focus.
|
| Consultation
question 3: Do you agree with our proposal to allow students studying
for an ELQ to count towards the delivery of separately monitored co-funded
additional student numbers (ASNs)? |
This seems pragmatic and clearly sits comfortably with the employer
engagement agenda. However, it must be recognised that the nature
of some of the existing sophisticated and deep partnerships, for example
with the NHS, cannot be quantified by the simple payment of fees.
Particularly at the post-graduate level of pharmacist practitioner
development, there are numerous examples of 'in-kind' contributions
from the NHS, including the mentoring of junior pharmacists as well
conventional face-to-face delivery using visiting lecturers and joint
appointments.
|
| Consultation
question 4: Do you agree with the proposal to introduce an allocation
for strategically important and vulnerable subjects (SIVS), calculated
on the basis of ELQ numbers studying SIVS? |
Yes. A number of SIV subjects feature prominently in the Pharmacy
curriculum so the School of Pharmacy is keen to see that academic
capacity in these subjects is maintained and developed. A number of
the subjects, including medicinal, pharmaceutical chemistry and structural
chemistry are crucial to drug discovery programmes. Moreover, pharmacists
play important roles across the pharmaceutical industry. In 2005,
UK pharmaceutical industry exports were approximately £12.2
billion, creating a surplus of £3.4 billion (source: Association
of British Pharmaceutical Industry).
|
| Consultation
question 5: Do you agree that we should provide a supplement to
the part-time targeted allocation? |
Yes.
|
Consultation
question 6: Do you agree with our proposal to provide 'safety
net' funding to maintain each institution's grant at a comparable
2007-08 level in cash terms?
|
Yes.
|
| Consultation
question 7: Do you consider that the ELQ policy outlined in this
document is likely to have a differential impact on students, depending
on their gender, race, whether they have a disability, or any other
extraneous factors? If so, how might this be mitigated? |
It seems
inevitable that those from minorities who have managed to acquire
a qualification but then wish to re-skill for another vocation, such
as pharmacy, will be least able to so and be hardest hit by these
proposals. In 2006/07 some 40% of new registrants with the Royal Pharmaceutical
Society of Great Britain were from ethnic minority backgrounds.
|
|
Consultation
question 8: Do you have any further comments?
|
The
ELQ proposals run completely counter to continuing professional
development, life-long learning and skills development. It makes
no sense (academic or otherwise) to bundle PG Certificates, Diplomas
and Masters together as equivalent qualifications.
- Within
the NHS, the Agenda for Change career framework is based on escalating
post-graduate qualifications (the KSF - Knowledge and Skills Framework).
- Extensive
use is made of PG Diploma and Masters qualifications in Pharmacy
to support NHS workforce development and enable the delivery of
important aspects of health policy.
- There
is a clear academic progression route and practitioners should
not be denied the opportunity build up their qualifications.
The context here is the development of the pharmacists clinical
role and specialisation as envisaged in Our Health, Our Care,
Our Say and Our NHS, Our Future. It is strongly recommended that
these planned professional programmes be exempted from the proposals
to withdraw funding for ELQ. They are clearly different from a
selection of unrelated programmes being chosen by students at
random.
<<<<<
|
|
|